752819055	752819055	CD	B-NP	O
|	|	NNP	I-NP	O
GNJRH	GNJRH	NNP	I-NP	O
|	|	VBD	B-VP	O
05992948	05992948	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
8537160	8537160	CD	B-NP	O
|	|	CC	I-NP	O
10/21/2005	10/21/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
HYPOKALEMIA	HYPOKALEMIA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Unsigned	Unsigned	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/21/2005	10/21/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Unsigned	Unsigned	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/18/2005	6/18/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SARCONE	SARCONE	NNP	B-NP	O
,	,	,	O	O
BERNARDO	BERNARDO	NNP	B-NP	O
BRADLEY	BRADLEY	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Weakness	Weakness	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Bacteremia	Bacteremia	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Giant	Giant	JJ	B-NP	O
cell	cell	NN	I-NP	O
arteritis	arteritis	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

CONSULTS	CONSULTS	NNS	B-NP	O
:	:	:	O	O
Neurology	Neurology	NN	B-NP	O
on	on	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
.	.	.	O	O

PROCEDURE	PROCEDURE	NN	B-NP	O
:	:	:	O	O
Attempted	Attempt	VBN	B-NP	O
lumbar	lumbar	NN	I-NP	O
puncture	puncture	NN	I-NP	O
on	on	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
81-year-old	81-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
giant	giant	JJ	B-NP	O
cell	cell	NN	I-NP	O
arteritis	arteritis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
preserved	preserve	VBN	B-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
generalized	generalize	VBN	B-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
children	child	NNS	I-NP	O
and	and	CC	I-NP	O
VNA	VNA	NN	I-NP	B-protein
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
in	in	IN	B-PP	O
touch	touch	NN	B-NP	O
with	with	IN	B-PP	O
him	him	PRP	B-NP	O
and	and	CC	O	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
house	house	NN	I-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
sitting	sit	VBG	I-VP	O
too	too	RB	B-ADJP	O
weak	weak	JJ	I-ADJP	O
to	to	TO	B-VP	O
answer	answer	VB	I-VP	O
the	the	DT	B-NP	O
door	door	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
apparently	apparently	RB	I-VP	O
confused	confuse	VBN	I-VP	O
and	and	CC	I-VP	O
disoriented	disorient	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
feeling	feel	VBG	I-VP	O
poorly	poorly	RB	B-ADVP	O
for	for	IN	B-PP	O
about	about	IN	B-NP	O
two	two	CD	I-NP	O
years	year	NNS	I-NP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
with	with	IN	B-PP	O
giant	giant	JJ	B-NP	O
cell	cell	NN	I-NP	O
arteritis	arteritis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
acute	acute	JJ	I-NP	O
change	change	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
focal	focal	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
slurred	slur	VBD	B-VP	O
speech	speech	NN	B-NP	O
,	,	,	I-NP	O
bowel	bowel	NN	I-NP	O
or	or	CC	I-NP	O
bladder	bladder	NN	I-NP	O
incontinence	incontinence	NN	I-NP	O
,	,	,	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
witnessed	witness	VBN	I-NP	O
seizure	seizure	NN	I-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
denied	deny	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
on	on	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
report	report	NN	I-NP	O
of	of	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
urinary	urinary	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
jaw	jaw	NN	B-NP	O
claudication	claudication	NN	I-NP	O
,	,	,	O	O
calf	calf	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
vision	vision	NN	B-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
think	think	VB	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
recently	recently	RB	I-VP	O
lost	lose	VBN	I-VP	O
weight	weight	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
chronic	chronic	JJ	B-NP	O
right	right	JJ	I-NP	O
shoulder	shoulder	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
pulse	pulse	NN	B-NP	O
of	of	IN	B-PP	O
78	78	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
124/60	124/60	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
breathing	breathing	NN	B-NP	O
16	16	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
low	low	JJ	B-ADJP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
head	head	NN	B-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
potassium	potassium	NN	B-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
repletion	repletion	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
oxycodone	oxycodone	NN	B-NP	O
for	for	IN	B-PP	O
right	right	JJ	B-NP	O
shoulder	shoulder	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
weakness	weakness	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypokalemia	hypokalemia	NN	B-NP	O
and	and	CC	I-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
preserved	preserve	VBN	B-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
s/p	s/p	NN	I-NP	O
DC	DC	NN	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
giant	giant	JJ	B-NP	O
cell	cell	NN	I-NP	O
arteritis	arteritis	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
status	status	NN	B-NP	O
post	post	VBP	B-VP	O
recent	recent	JJ	B-NP	O
left	left	JJ	I-NP	O
thigh	thigh	JJ	I-NP	O
ulcer	ulcer	NN	I-NP	O
excision	excision	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Coumadin	Coumadin	NN	B-NP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Medrol	Medrol	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
multivitamin	multivitamin	NN	B-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
cat	cat	NN	I-NP	B-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
son	son	NN	I-NP	O
visits	visit	VBZ	B-VP	O
him	him	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
but	but	CC	O	O
reports	report	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
use	use	NN	I-NP	O
of	of	IN	B-PP	O
one	one	CD	B-NP	O
drink	drink	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Vitals	Vital	NNS	B-NP	O
-	-	HYPH	O	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
74	74	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
105/51	105/51	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
18	18	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
sats	sat	NNS	B-NP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GEN	GEN	NN	B-NP	O
-	-	HYPH	I-NP	O
NAD	NAD	NN	I-NP	O
,	,	,	O	O
pleasant	pleasant	JJ	B-NP	O
elderly	elderly	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	B-protein
-	-	HYPH	O	O
MMM	MMM	NN	B-NP	O
,	,	,	O	O
oropharynx	oropharynx	NN	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
-	-	HYPH	I-NP	O
JVP	JVP	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
12	12	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

PULM	PULM	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
poor	poor	JJ	I-NP	O
inspiratory	inspiratory	JJ	I-NP	O
effort	effort	NN	I-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
side	side	NN	B-NP	O
mostly	mostly	RB	B-ADJP	O
clear	clear	JJ	I-ADJP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
and	and	CC	I-NP	O
rales	rale	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
-	-	HYPH	I-NP	O
regular	regular	JJ	I-NP	O
rate	rate	NN	I-NP	O
with	with	IN	B-PP	O
early	early	JJ	B-NP	O
beats	beat	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rubs	rub	NNS	B-NP	O
appreciated	appreciate	VBN	B-VP	O
.	.	.	O	O

ABD	ABD	NN	B-NP	O
-	-	HYPH	B-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

EXT	EXT	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
+	+	SYM	B-NP	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
knees	knee	NNS	B-NP	O
,	,	,	O	O
faint	faint	JJ	B-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
thigh	thigh	JJ	B-NP	O
sutures	suture	NNS	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
surrounding	surround	VBG	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	AFX	B-NP	B-protein
-	-	HYPH	I-NP	I-protein
cranial	cranial	JJ	B-NP	I-protein
nerves	nerve	NNS	I-NP	I-protein
II	II	CD	B-NP	I-protein
through	through	IN	B-PP	O
XII	XII	CD	B-NP	B-DNA
grossly	grossly	RB	I-NP	O
intact	intact	JJ	I-NP	O
,	,	,	I-NP	O
motor	motor	JJ	I-NP	O
strength	strength	NN	I-NP	O
is	be	VBZ	B-VP	O
5/5	5/5	CD	B-NP	O
throughout	throughout	IN	B-ADVP	O
except	except	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
deltoid	deltoid	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
limited	limit	VBN	I-VP	O
by	by	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
hip	hip	NN	I-NP	O
flexors	flexor	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
4/5	4/5	CD	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
78	78	CD	B-NP	O
,	,	,	O	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
aVL	aVL	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
old	old	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
hypotension	hypotension	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
,	,	,	O	O
stress	stress	NN	B-NP	O
dose	dose	NN	I-NP	O
steroids	steroid	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
broader	broad	JJR	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
acyclovir	acyclovir	NN	B-NP	O
with	with	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
encephalopathy	encephalopathy	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
increased	increase	VBN	B-NP	O
lethargy	lethargy	NN	I-NP	O
and	and	CC	O	O
right-sided	right-sided	JJ	B-NP	O
deficits	deficit	NNS	I-NP	O
reported	report	VBD	B-VP	O
earlier	earlier	RBR	B-ADVP	O
that	that	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
responded	respond	VBD	B-VP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
pressor	pressor	NN	B-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
lumbar	lumbar	NN	I-NP	O
puncture	puncture	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
unsuccessful	unsuccessful	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
from	from	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
a.m.	a.m.	NN	I-NP	O
grew	grow	VBD	B-VP	O
gram-negative	gram-negative	JJ	B-NP	O
rods	rod	NNS	I-NP	O
and	and	CC	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
for	for	IN	B-PP	O
double	double	JJ	B-NP	O
gram-negative	gram-negative	JJ	I-NP	O
coverage	coverage	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
other	other	JJ	I-NP	O
cultures	culture	NNS	I-NP	O
grew	grow	VBD	B-VP	O
one	one	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
four	four	CD	I-NP	O
pansensitive	pansensitive	JJ	I-NP	O
pseudomonas	pseudomona	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
four	four	CD	I-NP	O
Bacteroides	Bacteroide	NNS	I-NP	O
fragilis	fragilis	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
acyclovir	acyclovir	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-NP	O
and	and	CC	I-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
origin	origin	NN	I-NP	O
given	give	VBN	B-VP	O
its	its	PRP$	B-NP	O
species	specie	NNS	I-NP	O
and	and	CC	O	O
would	would	MD	B-VP	O
consider	consider	VB	I-VP	O
microperforation	microperforation	NN	B-NP	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
possibility	possibility	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
sources	source	NNS	I-NP	O
include	include	VBP	B-VP	O
sinusitis	sinusitis	NN	B-NP	O
and	and	CC	O	O
recent	recent	JJ	B-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
were	be	VBD	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
to	to	TO	B-VP	O
result	result	VB	I-VP	O
in	in	IN	B-PP	O
pseudomonas	pseudomona	NNS	B-NP	O
and	and	CC	I-NP	O
Bacteroides	Bacteroide	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
-	-	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
generalized	generalize	VBN	B-NP	O
nonfocal	nonfocal	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
focal	focal	JJ	B-NP	O
right-sided	right-sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
aphasia	aphasia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lethargy/confusion	lethargy/confusion	NN	B-NP	O
.	.	.	O	O

Stat	Stat	NN	B-NP	B-protein
head	head	NN	I-NP	I-protein
CT/CTA	CT/CTA	NN	I-NP	I-protein
and	and	CC	O	O
neuro	neuro	NN	B-NP	O
consult	consult	NN	I-NP	O
were	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
acyclovir	acyclovir	NN	B-NP	O
for	for	IN	B-PP	O
concern	concern	NN	B-NP	O
of	of	IN	B-PP	O
CNS	CNS	NN	B-NP	B-protein
infection	infection	NN	I-NP	O
.	.	.	O	O

Lumbar	Lumbar	NN	B-NP	O
puncture	puncture	NN	I-NP	O
was	be	VBD	B-VP	O
attempted	attempt	VBN	I-VP	O
but	but	CC	O	O
was	be	VBD	B-VP	O
unsuccessful	unsuccessful	JJ	B-ADJP	O
.	.	.	O	O

CTA	CTA	NN	B-NP	B-protein
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
and	and	CC	I-NP	O
MRI/MRA	MRI/MRA	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
right-sided	right-sided	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
were	be	VBD	B-VP	O
transient	transient	JJ	B-ADJP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
also	also	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
cause	cause	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
included	include	VBD	B-VP	O
giant	giant	JJ	B-NP	O
cell	cell	NN	I-NP	O
arteritis	arteritis	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
,	,	,	O	O
recrudescence	recrudescence	NN	B-NP	O
of	of	IN	B-PP	O
previous	previous	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
,	,	,	O	O
transient	transient	JJ	B-NP	O
hypotension	hypotension	NN	I-NP	O
from	from	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
and	and	CC	I-NP	O
TIA	TIA	NN	I-NP	O
.	.	.	O	O

Interestingly	Interestingly	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
chart	chart	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
initial	initial	JJ	I-NP	O
ED	ED	NN	I-NP	O
nursing	nursing	NN	I-NP	O
note	note	NN	I-NP	O
per	per	IN	B-PP	O
EMS	EMS	NNP	B-NP	O
reported	report	VBD	B-VP	O
right-sided	right-sided	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
must	must	MD	B-VP	O
have	have	VB	I-VP	O
been	be	VBN	I-VP	O
transient	transient	JJ	B-ADJP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
ED	ED	JJ	I-NP	O
physician	physician	NN	I-NP	O
note	note	NN	I-NP	O
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
focality	focality	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CV/Pulm	CV/Pulm	NN	B-NP	O
-	-	HYPH	O	O
-LRB-	-LRB-	SYM	B-NP	O
I	I	PRP	B-NP	O
-RRB-	-RRB-	VBP	B-VP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denied	deny	VBD	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
troponin	troponin	NN	B-NP	B-protein
was	be	VBD	B-VP	I-protein
negative	negative	JJ	B-NP	I-protein
x	x	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
P	P	NN	B-NP	O
-RRB-	-RRB-	SYM	O	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
given	give	VBN	I-VP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
9/23/05	9/23/05	CD	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
chest	ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
clear	clear	JJ	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
sats	sat	NNS	I-NP	O
were	be	VBD	B-VP	O
94	94	CD	B-NP	O
to	to	TO	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
required	require	VBD	B-VP	O
aggressive	aggressive	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
resuscitation	resuscitation	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
hypotension	hypotension	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
again	again	RB	B-ADVP	O
became	become	VBD	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
2/27/05	2/27/05	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mildly	mildly	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
on	on	IN	B-PP	O
daily	daily	JJ	B-NP	O
p.o.	p.o.	NN	I-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
R	R	NN	B-NP	B-protein
-RRB-	-RRB-	SYM	O	I-protein
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
DC	DC	NN	I-NP	O
cardioversion	cardioversion	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
presented	present	VBD	B-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
require	require	VB	I-VP	O
IV	IV	CD	B-NP	O
Lopressor	Lopressor	NN	I-NP	O
and	and	CC	I-NP	O
verapamil	verapamil	NN	I-NP	O
for	for	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
rate	rate	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
flutter	flutter	NN	I-NP	O
on	on	IN	B-PP	O
5/25/05	5/25/05	CD	B-NP	O
to	to	TO	B-PP	O
2/27/05	2/27/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
refractory	refractory	JJ	I-ADJP	O
to	to	TO	B-PP	O
treatment	treatment	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
rate	rate	NN	I-NP	O
quickly	quickly	RB	B-ADVP	O
improved	improve	VBD	B-VP	O
on	on	IN	B-PP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
voiding	void	VBG	B-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
bladder	bladder	NN	I-NP	O
residual	residual	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
ranged	range	VBD	B-VP	O
from	from	IN	B-PP	O
1.5	1.5	CD	B-NP	O
to	to	TO	B-PP	O
1.9	1.9	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
on	on	IN	B-PP	O
5/25/05	5/25/05	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
and	and	CC	I-NP	O
urgency	urgency	NN	I-NP	O
on	on	IN	B-PP	O
2/27/05	2/27/05	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
and	and	CC	I-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
postvoid	postvoid	JJ	B-NP	O
residual	residual	NN	I-NP	O
was	be	VBD	B-VP	O
one	one	CD	B-NP	O
liter	liter	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
Foley	Foley	NNP	I-NP	O
was	be	VBD	B-VP	O
replaced	replace	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
trial	trial	NN	I-NP	O
to	to	TO	B-PP	O
void	void	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
completed	complete	VBN	I-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
be	be	VB	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
declined	decline	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
family	family	NN	I-NP	O
were	be	VBD	B-VP	O
informed	inform	VBN	I-VP	O
of	of	IN	B-PP	O
our	our	PRP$	B-NP	O
recommendation	recommendation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
scheduled	schedule	VBN	B-VP	O
who	who	WP	B-NP	O
are	be	VBP	B-VP	O
aware	aware	JJ	B-ADJP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
difficulty	difficulty	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
check	check	VB	I-VP	O
postvoid	postvoid	JJ	B-NP	O
residual	residual	JJ	I-NP	O
and	and	CC	O	O
replace	replace	VB	B-VP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
or	or	CC	O	O
teach	teach	VB	B-VP	O
straight	straight	JJ	B-NP	O
cath	cath	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
previously	previously	RB	B-ADVP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
leg	leg	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
excision	excision	NN	I-NP	O
and	and	CC	O	O
presented	present	VBN	B-VP	O
subtherapeutic	subtherapeutic	JJ	B-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
,	,	,	O	O
but	but	CC	O	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
CMH	CMH	NN	B-NP	O
Anticoagulation	Anticoagulation	NN	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Derm	Derm	NN	B-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
leg	leg	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
excision	excision	NN	I-NP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
sutures	suture	NNS	B-NP	O
removed	remove	VBN	B-VP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
at	at	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
post	post	JJ	I-NP	O
excision	excision	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
site	site	NN	I-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
unlikely	unlikely	JJ	I-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Rheum/Endocrine	Rheum/Endocrine	NN	B-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
giant	giant	JJ	B-NP	O
cell	cell	NN	I-NP	O
arteritis	arteritis	NN	I-NP	O
.	.	.	O	O

ESR	ESR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
to	to	TO	B-PP	O
99	99	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
Medrol	Medrol	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
of	of	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
right-sided	right-sided	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	O	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
change	change	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
high-dose	high-dose	JJ	B-NP	O
Solu-Medrol	Solu-Medrol	NN	I-NP	O
with	with	IN	B-PP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
GCA	GCA	NN	I-NP	O
exacerbation/vasculitis	exacerbation/vasculitis	NN	I-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
the	the	DT	B-NP	O
cultures	culture	NNS	I-NP	O
grew	grow	VBD	B-VP	O
preliminary	preliminary	JJ	B-NP	O
gram-negative	gram-negative	JJ	I-NP	O
rods	rod	NNS	I-NP	O
and	and	CC	O	O
MRI	MRI	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
vasculitis	vasculitis	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	I-VP	O
stress	stress	VB	I-VP	O
dose	dose	NN	B-NP	O
hydrocortisone	hydrocortisone	NN	I-NP	O
.	.	.	O	O

Steroids	Steroid	NNS	B-NP	O
were	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
during	during	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
continued	continued	JJ	I-NP	O
taper	taper	NN	I-NP	O
back	back	RB	B-ADVP	O
over	over	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
Medrol	Medrol	NN	I-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
an	an	DT	B-NP	O
inpatient	inpatient	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
insulin	insulin	NN	B-NP	B-protein
for	for	IN	B-PP	O
more	more	RBR	B-NP	O
aggressive	aggressive	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
twice	twice	RB	B-ADJP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
insulin	insulin	NN	I-NP	O
70/30	70/30	CD	I-NP	O
while	while	IN	B-SBAR	O
recovering	recover	VBG	B-VP	O
and	and	CC	I-VP	O
tapering	taper	VBG	I-VP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

As	As	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
to	to	TO	I-VP	O
resume	resume	VB	I-VP	O
his	his	PRP$	B-NP	O
oral	oral	JJ	I-NP	O
agents	agent	NNS	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Access	Access	NN	B-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
internal	internal	JJ	I-NP	O
jugular	jugular	JJ	I-NP	O
central	central	JJ	I-NP	O
venous	venous	JJ	I-NP	O
line	line	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
for	for	IN	B-PP	O
home	home	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
hypokalemia	hypokalemia	NN	B-NP	O
to	to	TO	B-PP	O
2.9	2.9	CD	B-NP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
repletion	repletion	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
was	be	VBD	B-VP	O
3.1	3.1	CD	B-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
additional	additional	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
40	40	CD	B-NP	O
mEq	mEq	NN	I-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
his	his	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
rechecked	rechecke	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
receiving	receive	VBG	B-VP	O
daily	daily	JJ	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
more	more	RBR	B-NP	O
aggressive	aggressive	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
repletion	repletion	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
-	-	HYPH	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Nexium	Nexium	NN	B-NP	O
and	and	CC	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
.	.	.	O	O

RADIOLOGICAL	RADIOLOGICAL	JJ	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CT	CT	NN	B-NP	O
head	head	NN	I-NP	O
on	on	IN	B-PP	O
2/7/05	2/7/05	CD	B-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
intracranial	intracranial	JJ	I-NP	O
abnormality	abnormality	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
maxillary	maxillary	JJ	I-NP	O
and	and	CC	I-NP	O
ethmoid	ethmoid	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
mucosal	mucosal	JJ	I-NP	O
thickening	thickening	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Portable	Portable	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
2/7/05	2/7/05	CD	B-NP	O
-	-	HYPH	I-NP	O
mild	mild	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

PA	PA	NN	B-NP	O
and	and	CC	I-NP	O
lateral	lateral	JJ	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
on	on	IN	B-PP	O
2/7/05	2/7/05	CD	B-NP	O
-	-	HYPH	O	O
stable	stable	JJ	B-ADJP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

CTA	CTA	NN	B-NP	O
head	head	NN	I-NP	O
,	,	,	O	O
9/23/05	9/23/05	CD	B-NP	O
-	-	HYPH	I-NP	O
paraventricular	paraventricular	JJ	I-NP	O
white	white	JJ	I-NP	O
matter	matter	NN	I-NP	O
changes	change	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
;	;	:	O	O
mild-to-moderate	mild-to-moderate	JJ	B-NP	O
atrophy	atrophy	NN	I-NP	O
with	with	IN	B-PP	O
compensatory	compensatory	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
megaly	megaly	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
-	-	HYPH	I-NP	O
to-moderate	to-moderate	JJ	I-NP	O
proximal	proximal	JJ	I-NP	O
right	right	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
calcification	calcification	NN	B-NP	O
and	and	CC	I-NP	O
atheroma	atheroma	NN	I-NP	O
;	;	:	O	O
calcifications	calcification	NNS	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	B-DNA
segments	segment	NNS	I-NP	I-DNA
at	at	IN	B-PP	O
the	the	DT	B-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
arteries	artery	NNS	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
bifurcation	bifurcation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
left	left	JJ	I-NP	O
internal	internal	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
appreciable	appreciable	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
and	and	CC	I-NP	O
calcification	calcification	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
narrowing	narrowing	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
vertebral	vertebral	JJ	I-NP	O
artery	artery	NN	I-NP	O
;	;	:	O	O
complete	complete	JJ	B-NP	O
opacification	opacification	NN	I-NP	O
of	of	IN	B-PP	O
bilateral	bilateral	JJ	B-NP	O
maxillary	maxillary	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
,	,	,	O	O
mucosal	mucosal	JJ	B-NP	O
thickening	thickening	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
ethmoid	ethmoid	NN	I-NP	O
and	and	CC	O	O
sphenoid	sphenoid	JJ	B-NP	O
sinuses	sinus	NNS	I-NP	O
;	;	:	O	O
degenerative	degenerative	JJ	B-NP	O
changes	change	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
spine	spine	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Portable	Portable	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
9/23/05	9/23/05	CD	B-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
silhouette	silhouette	NN	I-NP	O
or	or	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
parenchyma	parenchyma	NN	I-NP	O
from	from	IN	B-PP	O
2/7/05	2/7/05	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Portable	Portable	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
9/23/05	9/23/05	CD	B-NP	O
-	-	HYPH	O	O
improved	improve	VBN	B-NP	O
aeration	aeration	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lung	lung	NN	I-NP	O
base	base	NN	I-NP	O
allowing	allow	VBG	B-VP	O
visualization	visualization	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
hemidiaphragm	hemidiaphragm	NN	I-NP	O
;	;	:	O	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
jugular	jugular	JJ	I-NP	O
central	central	JJ	I-NP	O
venous	venous	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
with	with	IN	B-PP	O
tip	tip	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
SVC	SVC	NN	I-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
pneumothorax	pneumothorax	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

MR	MR	NN	B-NP	B-protein
of	of	IN	B-PP	O
the	the	DT	B-NP	O
brain	brain	NN	I-NP	O
with	with	IN	B-PP	O
and	and	CC	B-PP	O
without	without	IN	B-PP	O
contrast	contrast	NN	B-NP	O
,	,	,	O	O
9/23/05	9/23/05	CD	B-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
intracranial	intracranial	JJ	I-NP	O
collections	collection	NNS	I-NP	O
of	of	IN	B-PP	O
mass	mass	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
;	;	:	O	O
mild	mild	JJ	B-NP	O
involutional	involutional	JJ	I-NP	O
changes	change	NNS	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Portable	Portable	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
7/5/05	7/5/05	CD	B-NP	O
,	,	,	O	O
bibasilar	bibasilar	JJ	B-NP	O
opacities	opacity	NNS	I-NP	O
due	due	JJ	B-ADJP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
in	in	IN	B-PP	O
part	part	NN	B-NP	O
to	to	TO	B-PP	O
atelectasis	atelectasis	NN	B-NP	O
;	;	:	O	O
right	right	JJ	B-NP	O
jugular	jugular	JJ	I-NP	O
central	central	JJ	I-NP	O
venous	venous	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
position	position	NN	B-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
substantial	substantial	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
or	or	CC	I-NP	O
pneumothorax	pneumothorax	NN	I-NP	O
.	.	.	O	O

CARDIOLOGY	CARDIOLOGY	NN	B-NP	O
STUDIES	STUDIES	NNS	I-NP	O
:	:	:	O	O
Echocardiogram	Echocardiogram	NN	B-NP	O
on	on	IN	B-PP	O
7/5/05	7/5/05	CD	B-NP	O
-	-	HYPH	I-NP	O
normal	normal	JJ	I-NP	O
LV	LV	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
;	;	:	O	O
normal	normal	JJ	B-NP	O
RV	RV	NN	I-NP	O
;	;	:	O	O
atrial	atrial	JJ	B-NP	O
size	size	NN	I-NP	O
normal	normal	JJ	B-ADJP	O
;	;	:	O	O
trace	trace	NN	B-NP	O
to	to	TO	B-PP	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
;	;	:	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
PAP	PAP	NN	B-NP	B-protein
38	38	CD	I-NP	I-protein
.	.	.	O	O

MICROBIOLOGICAL	MICROBIOLOGICAL	JJ	B-NP	O
STUDY	STUDY	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
,	,	,	O	O
9/23/05	9/23/05	CD	B-NP	O
admission	admission	NN	I-NP	O
-	-	HYPH	B-NP	O
one	one	CD	I-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
four	four	CD	I-NP	O
Bacteroides	Bacteroide	NNS	I-NP	O
fragilis	fragilis	NN	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
four	four	CD	I-NP	O
pansensitive	pansensitive	JJ	I-NP	O
Pseudomonas	Pseudomonas	NNP	I-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
,	,	,	O	O
9/23/05	9/23/05	CD	B-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
9/23/05	9/23/05	CD	B-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
culture	culture	NN	I-NP	O
,	,	,	O	O
2/27/05	2/27/05	CD	B-NP	O
-	-	HYPH	O	O
negative	negative	JJ	B-ADJP	O
with	with	IN	B-PP	O
total	total	JJ	B-NP	O
colony	colony	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
1000	1000	CD	B-NP	O
yeast	yeast	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

VRE	VRE	NN	B-NP	O
and	and	CC	I-NP	O
MRSA	MRSA	NN	I-NP	O
screen	screen	NN	I-NP	O
on	on	IN	B-PP	O
9/23/05	9/23/05	CD	B-NP	O
-	-	HYPH	I-NP	O
negative	negative	JJ	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

C.	C.	FW	B-NP	O
diff	diff	FW	I-NP	O
screen	screen	NN	I-NP	O
on	on	IN	B-PP	O
2/27/05	2/27/05	CD	B-NP	O
-	-	HYPH	I-NP	O
negative	negative	JJ	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
9/19/05	9/19/05	CD	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
headache	headache	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Enteric-coated	Enteric-coated	JJ	B-NP	O
aspirin	aspirin	NN	I-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Atenolol	Atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Ceftazidime	Ceftazidime	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

with	with	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
dose	dose	NN	I-NP	O
on	on	IN	B-PP	O
3/23/05	3/23/05	CD	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Medrol	Medrol	NN	B-NP	O
taper	taper	NN	I-NP	O
12	12	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
x4	x4	CD	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
x4	x4	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
8	8	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
x4	x4	CD	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
then	then	RB	O	O
6	6	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
12	12	CD	I-NP	O
hours	hour	NNS	I-NP	O
x4	x4	CD	B-NP	O
doses	dose	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	B-VP	O
continue	continue	VBP	I-VP	O
methylprednisolone	methylprednisolone	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
24h	24h	NN	I-NP	O
.	.	.	O	O

indefinitely	indefinitely	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Flagyl	Flagyl	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
1.25	1.25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Zocor	Zocor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	O
70/30	70/30	CD	I-NP	O
,	,	,	I-NP	O
20	20	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
12	12	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Levofloxacin	Levofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
to	to	TO	B-VP	O
end	end	VB	I-VP	O
on	on	IN	B-PP	O
3/23/05	3/23/05	CD	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Flomax	Flomax	NN	B-NP	O
0.4	0.4	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
subcu	subcu	NN	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
only	only	RB	B-ADVP	O
at	at	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	I-NP	O
dinner	dinner	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

TO	TO	TO	B-VP	O
DO/PLAN	DO/PLAN	NN	I-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Medication	Medication	NN	B-NP	O
changes	change	NNS	I-NP	O
:	:	:	O	O
holding	hold	VBG	B-VP	O
lisinopril	lisinopril	NN	B-NP	O
and	and	CC	I-NP	O
glyburide	glyburide	NN	I-NP	O
;	;	:	O	O
reducing	reduce	VBG	B-VP	O
Lasix	Lasix	NN	B-NP	O
from	from	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
to	to	TO	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
;	;	:	O	O
Coumadin	Coumadin	NN	B-NP	O
dose	dose	NN	I-NP	O
halved	halve	VBD	B-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
-LRB-	-LRB-	SYM	B-VP	O
ACH	ACH	NN	B-NP	O
Anticoagulation	Anticoagulation	NN	I-NP	O
may	may	MD	B-VP	O
adjust	adjust	VB	I-VP	O
this	this	DT	B-NP	O
based	base	VBN	B-PP	O
on	on	IN	B-PP	O
lab	lab	NN	B-NP	B-protein
values	value	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
;	;	:	O	O
steroid	steroid	NN	B-NP	O
taper	taper	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
week	week	NN	I-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
original	original	JJ	I-NP	O
dose	dose	NN	I-NP	O
;	;	:	O	O
last	last	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
on	on	IN	B-PP	O
3/23/05	3/23/05	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
can	can	MD	B-VP	O
be	be	VB	I-VP	O
removed	remove	VBN	I-VP	O
when	when	WRB	B-ADVP	O
his	his	PRP$	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
is	be	VBZ	B-VP	O
complete	complete	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
while	while	IN	B-SBAR	O
recovering	recover	VBG	B-VP	O
.	.	.	O	O

Possibility	Possibility	NN	B-NP	O
to	to	TO	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
glyburide	glyburide	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
discussed	discuss	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
once	once	IN	B-SBAR	O
steroid	steroid	NN	B-NP	O
taper	taper	NN	I-NP	O
and	and	CC	O	O
antibiotics	antibiotic	NNS	B-NP	O
completed	complete	VBN	B-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
be	be	VB	B-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
difficulty	difficulty	NN	I-NP	O
voiding	void	VBG	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
declined	decline	VBD	B-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
ability	ability	NN	I-NP	O
to	to	TO	B-PP	O
void	void	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
assessed	assess	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
VNA	VNA	NNP	I-NP	O
Services	Service	NNPS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
straight	straight	RB	I-VP	O
cathed	cathe	VBN	I-VP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
record	record	VB	I-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
keep	keep	VB	B-VP	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
log	log	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
presented	present	VBN	I-VP	O
at	at	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
within	within	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
and	and	CC	O	O
have	have	VB	B-VP	O
lytes	lyte	NNS	B-NP	O
checked	check	VBD	B-VP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
VNA	VNA	NNP	I-NP	O
Services	Service	NNPS	I-NP	O
should	should	MD	B-VP	O
check	check	VB	I-VP	O
a	a	DT	B-NP	O
Chem-7	Chem-7	NNP	I-NP	O
on	on	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
following	follow	VBG	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
ITMC	ITMC	NNP	B-NP	O
Anticoagulation	Anticoagulation	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
391-697-7896	391-697-7896	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-2360587	3-2360587	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
NEIL	NEIL	NNP	B-NP	O
,	,	,	O	O
ISSAC	ISSAC	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ESKRA	ESKRA	NNP	B-NP	O
,	,	,	O	O
NOBLE	NOBLE	NNP	B-NP	O
RILEY	RILEY	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7446715	7446715	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/29/05	5/29/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/29/05	5/29/05	CD	B-NP	O

